Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Rev Esp Quimioter ; 34(5): 491-495, 2021 Oct.
Artigo em Espanhol | MEDLINE | ID: mdl-34266230

RESUMO

OBJECTIVE: Currently the prevalence of pneumococcal coinfection in patients with COVID-19 is unknown. In this work we present its clinical characteristics, evolution and treatment. METHODS: Retrospective data collection from August to October 2020 in two hospitals in the Murcia region. RESULTS: Eighteen patients had COVID-19 diagnosed by PCR and pneumococcal infection confirmed by antigenuria, which represented a prevalence of 2%. A total of 88% had radiological alterations upon admission (two patients had an X-ray within normality) and 29% had elevated procalcitonin. Mortality in our series was 12%. CONCLUSIONS: It could be reasonable to consider the start of antimicrobial therapy in those cases in which there is a moderate or high suspicion of bacterial coinfection, being essential the early suspension of antibiotic treatment if it is not confirmed.


Assuntos
COVID-19 , Coinfecção , Coinfecção/tratamento farmacológico , Humanos , Estudos Retrospectivos , SARS-CoV-2 , Streptococcus pneumoniae
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...